院士簡歷

Division of Life Sciences

Hui-Kuan Lin 林慧觀
Election Year 2022
Duke University School of Medicine
210 Research Drive, GSRB2 building, Room 4012, Durham, NC 27710, USA
Tel: (919)684-3871

Current Positions

Tenured Professor and Director of Prostate Cancer Research, Endowed Chair Professor (Appointment in process), Department of Pathology, Duke University School of Medicine

Education

National Taiwan University, Taipei, Taiwan, BS, 1993, Pharmacy
National Taiwan University, Taipei, Taiwan, MS, 1995, Pharmacology
University of Rochester, Rochester, NY, Ph.D., 2002, Pathology (Cancer Biology)
Postdoctoral Study, Memorial Sloan-Kettering Cancer Center, New York, NY, 2002-2007

Professional Experience

Research Associate, Memorial Sloan Kettering Cancer Center, New York, 2005-2007
Faculty, Graduate School of Biomedical Sciences, The UT Health Science Center, Houston, TX, 2007-2015
Assistant Professor, Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 02/2007-08/2011
Associate Professor, Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 09/2011-08/2015
Professor, Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC 27101, 08/2015-04/2023
Director of Prostate Cancer Center of Excellence, Wake Forest University School of Medicine, 08/2015-04/2023
Director of Signaling and Biotechnology Program, Wake Forest Comprehensive Cancer Center, Winston-Salem, NC 27101, 2018-2020
Co-Director of Signaling and Biotechnology Program, Wake Forest Comprehensive Cancer Center, Winston-Salem, NC 27101, 2021-04/2023
Director of Prostate Cancer Research, Department of Pathology, Duke University School of Medicine, 05/2023-Present
Tenured Professor, Department of Pathology, Duke University School of Medicine, 06/2023-Present
Member of the Duke Cancer Institute, 06/15/2023-Present
Molecular Cancer Biology (MCB) Faculty, Duke University School of Medicine, 07/03/2023-Present
Endowed Chair Professor (Appointment in Process), Department of Pathology, Duke University School of Medicine

Specialties

Cancer, Signaling, Ubiquitination, Cell Metabolism

Awards and Honors

Gordon Research Travel Award, 1999
GSS travel award with Honorable Mention for Outstanding Quality, University of Rochester, 2000
First Author Student Award, Molecular Endocrinology, 2004
Travel Award, Annual Meeting of the American Society of Hematology, 2004
Research Trust Scholar of the UT MD Anderson Cancer Center, 2007-2012
New Investigator Award, Department of Defense, 2009-2011
Faculty Scholar Award, UT MD Anderson Cancer Center, 2011-2014
Young Investigator Award, SCBA, 2013
R. Lee Clark Fellow, 2014-2016
SCBA Award Committee, 2015
Key keynote speaker at Biomedical Conference, Toxicology, Taiwan (JACBS, 2014)
Selected as Anderson Professor for Cancer Research, Wake Forest University School of Medicine, 2015
Keynote speaker at Symposium of Formosa Medical Association, Taipei, Taiwan, 2016
Program Committee of AACR Annual Meeting, 2017
Member of OWIMS, Wake Forest School of Medicine, 2017
SCBA Poster Award Committee, 2019
Academic Advisory Committee of the Institute of Biomedical Sciences (IBMS) at Academia Sinica, 2020-Present
AACR Basic Cancer Research Grants Scientific Review Committee, 2021-Present
Elected to the Fellow of American Association for the Advancement of Science (AAAS), 2022-Present
Elected to Academician of Academia Sinica, 2022-Present
Wake Forest University School of Medicine Established Investigator Award, 11/2022
Keynote speaker at 37th Joint Annual Conference of Biomedical Science, 03/2023
Keynote speaker at 27th Taiwan Joint Cancer Conference (TJCC 2023), 05/2023
Distinguished Alumni Award from School of Pharmacy, National Taiwan University, 5/17/2023